Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/18987320

Proc. Natl. Acad. Sci. U.S.A. 2008 Nov 11 105 45 17481-6

Download in:

View as

Triples

General Info

PMID
18987320